Chemoinformaics analysis of Holarrhimine/Kurchicine
| Molecular Weight | 332.532 | nRot | 2 |
| Heavy Atom Molecular Weight | 296.244 | nRig | 20 |
| Exact Molecular Weight | 332.283 | nRing | 4 |
| Solubility: LogS | -2.724 | nHRing | 0 |
| Solubility: LogP | 2.725 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 2 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 62.0765 |
| nHD | 3 | BPOL | 34.9755 |
| QED | 0.68 |
| Synth | 4.679 |
| Natural Product Likeliness | 2.941 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.021 |
| Pgp-sub | 0.002 |
| HIA | 0.041 |
| CACO-2 | -5.423 |
| MDCK | 0.00000756 |
| BBB | 0.503 |
| PPB | 0.700215 |
| VDSS | 0.642 |
| FU | 0.194799 |
| CYP1A2-inh | 0.062 |
| CYP1A2-sub | 0.079 |
| CYP2c19-inh | 0.019 |
| CYP2c19-sub | 0.646 |
| CYP2c9-inh | 0.044 |
| CYP2c9-sub | 0.018 |
| CYP2d6-inh | 0.852 |
| CYP2d6-sub | 0.896 |
| CYP3a4-inh | 0.52 |
| CYP3a4-sub | 0.275 |
| CL | 14.614 |
| T12 | 0.067 |
| hERG | 0.27 |
| Ames | 0.011 |
| ROA | 0.202 |
| SkinSen | 0.032 |
| Carcinogencity | 0.301 |
| EI | 0.006 |
| Respiratory | 0.968 |
| NR-Aromatase | 0.238 |
| Antiviral | No |
| Prediction | 0.591243 |